Most Common Symptoms of Insulinoma
The most common symptoms of insulinoma are hypoglycemic manifestations consisting of neuroglycopenic symptoms (confusion, altered mental status, visual disturbances, weakness, seizures) and adrenergic/autonomic symptoms (diaphoresis/sweating, tremors, palpitations, tachycardia), which are characteristically relieved by sugar intake 1.
Clinical Presentation Pattern
The hallmark presentation follows a predictable pattern of fasting hypoglycemia or hypoglycemia unrelated to meals 2. These episodes combine two distinct symptom categories:
Neuroglycopenic Symptoms (Brain Glucose Deprivation)
- Altered mental status/confusion - most frequently reported in recent series (68% loss of consciousness) 3
- Seizures - can be the presenting manifestation 4
- Visual disturbances
- Weakness
- Syncope
- In severe cases: coma 5
Adrenergic/Autonomic Symptoms (Catecholamine Response)
- Sweating/diaphoresis - present in 59% of patients 3
- Tremors
- Palpitations and tachycardia
- Vertigo - reported in 56% 3
Critical Diagnostic Features
The symptoms have several distinguishing characteristics that aid diagnosis:
- Timing: Episodes occur during fasting states or between meals, not postprandially 2, 1
- Relief pattern: Symptoms resolve promptly with glucose or high glycemic index food consumption 1, 6
- Frequency: Can be recurrent over months to years (average 33.4 months from symptom onset to diagnosis in one series) 3
Important Clinical Pitfalls
Delayed diagnosis is common because neuroglycopenic symptoms may initially masquerade as primary neurological or psychiatric disease 4. The time from first symptom onset to diagnosis ranges from 1 month to 17 years 1. Patients may be misdiagnosed with seizure disorders, psychiatric conditions, or other neurological diseases before the hypoglycemic etiology is recognized.
In malignant insulinoma, symptoms may be more severe and prolonged due to greater insulin and proinsulin production from metastatic tumor burden, though severity does not strictly correlate with tumor burden 1.
Biochemical Confirmation
When symptoms occur, expect to find:
- Plasma glucose ≤ 0.45 g/L (45 mg/dL) with concurrent inappropriate insulin secretion
- Insulin ≥ 3 mU/L (≥ 61.1 pmol/L median) 1, 7
- Beta-hydroxybutyrate suppressed (median 0.3 mmol/L) 7
- Symptoms relieved by sugar intake - completing Whipple's triad 1, 6
The combination of these classic hypoglycemic symptoms with biochemical confirmation during a supervised fast (sometimes requiring up to 72 hours) establishes the diagnosis 2, 1.